hIL4/hIL4R
系統名
C57BL/6Smoc-Il4tm3(hIL4)Il4ratm1(hIL4R)Smoc
SMOC番号
NM-HU-2000106
維持形態
Repository Live
遺伝子の概要
Gene Symbol
IL4
Gene Symbol
IL4Ra
Gene Symbol
Il4
説明
表現型データ
Fig1. Analysis of hIL4 expression in serum by ELISA. The homozygous KI mice express hIL4 in serum after treatment with concanavalin.
Fig2. Analysis of hIL4R expression in the spleen by FACS. The homozygous KI mice express hIL4R in the spleen, and the WT mice only express mIL4R.
Fig3. Evaluation of an Anti-huIL4Ra mAb in the OXA-Induced Atopic Dermatitis Model in hIL4/hIL4Ra dKI Mice. Both dupilumab and Dexamethasone ameliorate overall atopic dermatitis activity in OXA - challenged ears, but only Dexamethasone worked in back skin. (In cooperation with CrownBio)
Fig4. Dupilumab significantly mitigates inflammatory cell infiltration in lesioned ear. (In cooperation with CrownBio)
Note: Inflammatory cell infiltration is indicated by black arrows, 10X images
Fig5. Low dose dupilumab significantly mitigates inflammatory cell infiltration in lesioned skin. (In cooperation with CrownBio)
Note: Inflammatory cell infiltration is indicated by black arrows, 10X images
Fig6. Dexamethasone and dupilumab treatments are well tolerated. Both significantly reduced IgE levels in serum but not spleen weight. (In cooperation with CrownBio)
Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.
Fig7. Repeated OXA-induced Th2 cytokine production (hIL-4 elevation) and dupilumab treatment significantly reduces IL-6 and KC/GRO levels in lesioned ear. (In cooperation with CrownBio)
Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.
Fig8. Repeated OXA-induced Th2 cytokine production (hIL-4 elevation) and dupilumab treatment significantly reduces IL-5 and IL-2 levels in lesioned skin. (In cooperation with CrownBio)
Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
詳細